GLP-1 Drugs Did Not Lower Relapse Risk in Crohn’s and Colitis Patients, a Large Claims Analysis Found

A claims study found GLP-1 drugs did not reduce IBD relapse in patients with obesity or diabetes, and did not raise safety events.

Have A Referral?